ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

NIAMDD Scientists Find Virus Gene Causes, Continues Cancer

May 9, 1975

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine

August 20, 1982

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005